United Kingdom

Showing 21-30 of 36 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Semaglutide as an add-on treatment to optimise glycaemic control in children and young people with type 1 diabetes	University of Birmingham	Timothy Barrett	Improving Lives	01-March-2023 to 28-February-2026	$1,782,815.00
Profiling The Kinome In Type 1 Diabetes; Identifying Novel Targets For Biomarker Development and Disease-modifying Therapies	University of Bristol	Anna Long	Cures	01-April-2025 to 30-September-2026	$197,076.23
The L selectin pathway in type 1 diabetes	University of Bristol	Kathleen Gillespie	Cures	01-September-2024 to 31-August-2027	$827,321.85
Pancreatic function; unanticipated insights into progression rate to type 1 diabetes	University of Bristol	Kathleen Gillespie	Cures	01-September-2024 to 31-August-2027	$545,259.92
Biological Signature of Diabetes Mellitus	University of Cambridge	Kourosh Saeb-Parsy	Cures	01-August-2023 to 31-July-2026	$514,959.00
Home-based measures of beta-cell function and CGM metrics to predict progression of pre-symptomatic individuals	University of Cambridge	M. Loredana Marcovecchio	Cures	01-October-2024 to 30-September-2027	$855,740.85
Sotagliflozin in Patients with Heart Failure Symptoms and Type 1 Diabetes (SOPHIST)	University of Dundee	Ify Mordi	Improving Lives	01-September-2023 to 31-August-2026	$1,783,962.00
Understanding the impact of endogenous insulin secretion on clinical outcomes in type 1 diabetes and the optimal approach to C-peptide measurement for outcome prediction	University of Exeter	Angus Jones	Cures	01-June-2025 to 31-May-2027	$581,477.00
Novel biomarkers for identification of adult-onset Type 1 diabetes	University of Exeter	Angus Jones	Cures	01-January-2026 to 31-December-2027	$898,312.00
Exploring an islet-protective role for native pancreatic mesenchymal stromal cells in health and in type 1 diabetes	University of Exeter	Chloe Rackham	Cures	01-April-2023 to 31-March-2026	$375,000.00